
GLP-1 Drugs Linked to Lower Psychiatric Acute Care in People With Schizophrenia and Type 2 Diabetes
GLP-1 drugs were linked to lower psychiatric acute care in patients with schizophrenia and type 2 diabetes, BMJ reports.
Studies on new and existing drugs and treatments, from early discovery to real-world results.

GLP-1 drugs were linked to lower psychiatric acute care in patients with schizophrenia and type 2 diabetes, BMJ reports.

UK medical research advances as new studies and funding signal progress toward better patient care and NHS impact.

Early trial data suggest a targeted multiple sclerosis therapy may retrain immunity without broadly suppressing the immune system.

BMJ study finds patient-centred digital adherence technology improved tuberculosis treatment outcomes in a pragmatic trial.

Nature Medicine reports a 38,753-patient analysis on heart-failure therapy effects on blood pressure, kidney function and potassium.

Nature Medicine reports a prospective emergency department AI study, advancing clinical decision support research in medicine.

Nature Medicine reports a pilot AI decision-support tool was safe in emergency care, but clinician use declined over four weeks.

Single-cell research reveals why some CAR-T therapies work better, offering new clues for more precise cancer treatment.

Setidegrasib shows early promise in a first clinical test for KRAS G12D-driven solid tumors.

NICE and MHRA launch a faster approval pathway that could bring new medicines to patients 3 to 6 months sooner.